Pharmaceutical preparations, namely, wound healing preparations, preparations for the prevention, reduction, inhibition or treatment of scarring, preparations for the treatment, reduction, inhibition or prevention of fibrosis, preparations for the treatment, inhibition or prevention of the development of fibrotic conditions, preparations for the purpose of prevention, reduction, inhibition or treatment of scarring in connection with surgery and trauma, treatment of nerves, surgery of nerves or trauma, preparations for the treatment, reduction, inhibition or prevention of dermal wounds, preparations for the treatment, reduction, inhibition or prevention of dermal scarring, preparations for the treatment, reduction, inhibition or prevention of dermal fibrotic conditions, preparations for the treatment of damaged ligaments, tendons or cartilage, preparations for the promotion of re-epithelialization, preparations for the treatment of chronic wounds, preparations for the treatment of burns, preparations for the treatment, reduction, inhibition or prevention of ulcers or pressure sores, preparations for the treatment, reduction, inhibition or prevention of adhesions and strictures, preparations for the treatment of cardiovascular and vascular restenosis, preparations for the purpose of prevention, reduction, inhibition or treatment of scarring in the treatment of the eye, preparations for the purpose of prevention, reduction, inhibition or treatment of scarring in the treatment of nerves, surgery of nerves or trauma; topical and injectable pharmaceutical preparations for the reduction of scarring, fibrosis and fibrotic conditions in human tissue resulting from surgery or trauma; topical and injectable pharmaceutical preparations, namely formulations of proteins that can stimulate the growth of cells for the prevention, reduction, inhibition or treatment of dermal scarring or fibrosis and the treatment, inhibition or prevention of the development of dermal fibrotic conditions; topical and injectable pharmaceutical preparations, namely formulations of proteins that can stimulate the growth of cells to aid in the optimal healing of incisions to epithelial and connective tissue after surgical incisions; devices for the delivery of topical and injectable pharmaceutical preparations, specifically transdermal patches; gels or creams for the delivery of topical and/or injectable pharmaceutical preparations, namely formulations of proteins that can stimulate the growth of cells for the prevention, reduction, inhibition or treatment of dermal scarring of fibrosis and the treatment, inhibition or prevention of the development of dermal fibrotic conditions

Devices for the delivery of topical and injectable pharmaceutical preparations, specifically hypodermic syringes, transdermal needle-free injection systems, microneedle injection systems